ArticleNature communications2022

Adipose-targeted triiodothyronine therapy counteracts obesity-related metabolic complications and atherosclerosis with negligible side effects.

Kang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.